The Orthopaedic Oncology and Sarcoma team provides multidisciplinary diagnostic, treatment and follow-up services for patients with cancers of the bone and soft tissue. Led by board-certified, nationally known physicians, the team delivers some of the most advanced care in the region, including access to clinical trials, limb-sparing surgery and minimally invasive techniques. Each patient’s case is reviewed by the Tumor Board experts to develop an individualized plan of care in accordance with National Comprehensive Cancer Network (NCCN) guidelines. Depending on patient need, other specialists throughout the hospital, for example plastic surgeons, pharmacologists, nutritionists, physical therapists or palliative care experts, will join the team to deliver seamless, coordinated care.
For patients with primary or secondary bone cancers, Stony Brook offers several pioneering options, including limb-sparing robot-assisted surgery —one of the few medical centers in the world with the expertise and technology to do so. This technique allows the surgeon to more accurately target the cancer cells and remove far less healthy tissue. For more information about theses services click here.
Far less common — just 1 percent of all cancer diagnoses nationally — is sarcoma, which are tumors occurring in the soft tissue, most frequently in the extremities. Because the cause is generally unknown and there seem to be no age, gender and race predisposition, prevention is not an option. And because many sarcomas show no symptoms, they often get diagnosed in later stages. Stony Brook’s team can offer expedited diagnosis and comprehensive treatment options including technologically advanced radiation, surgical and systemic therapies.